Prawo i regulacje · 21/04/2022

Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, Following Review of Proposed Transaction

The Federal Trade Commission has approved Pfizer's acquisition of BioNTech, following a review of the proposed transaction, which is expected to close in the first half of 2024, subject to certain conditions